Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab
Sign Up to like & getrecommendations! Published in 2017 at "Aging Clinical and Experimental Research"
DOI: 10.1007/s40520-017-0752-5
Abstract: to receive Ibrutinib are elderly and are likely to require anticoagulant or antiplatelet therapy owing to associated comorbidities, including atrial fibrillation and ischemic diseases. Besides, due to the multiple interactions of Ibrutinib with several TKs… read more here.
Keywords: plasma concentration; ibrutinib; increased dabigatran; dabigatran ... See more keywords